Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis
Pre-publication versions of this article are available by contacting email@example.com.
|1 Feb 2018||Submitted||Original manuscript|
|30 May 2018||Reviewed||Reviewer Report - Nontuthuko Excellent Maningi|
|7 Sep 2018||Reviewed||Reviewer Report - Willy Ssengooba|
|27 Sep 2018||Author responded||Author comments - Noura M. Al-Mutairi|
|Resubmission - Version 2|
|27 Sep 2018||Submitted||Manuscript version 2|
|21 Nov 2018||Reviewed||Reviewer Report - Willy Ssengooba|
|11 Dec 2018||Reviewed||Reviewer Report - Nontuthuko Excellent Maningi|
|16 Dec 2018||Author responded||Author comments - Noura M. Al-Mutairi|
|Resubmission - Version 3|
|16 Dec 2018||Submitted||Manuscript version 3|
|19 Dec 2018||Editorially accepted|
|3 Jan 2019||Article published||10.1186/s12879-018-3638-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.